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Influence of Cardiorespiratory Fitness on the Association
between C-Reactive Protein and Metabolic Syndrome
Prevalence in Racially Diverse Women
MICHAEL J. LAMONTE, Ph.D., M.P.H.,1 BARBARA E. AINSWORTH, Ph.D., M.P.H.,2
and J. LARRY DURSTINE, Ph.D.3
ABSTRACT
Background: Metabolic syndrome and C-reactive protein (CRP) are independent predictors of
cardiovascular disease (CVD) among women. The extent to which cardiorespiratory fitness
influences the relationship between CRP and metabolic syndrome is unknown.
Methods and Results: Cross-sectional associations among fitness, CRP, and metabolic syn-
drome were examined in 135 African American, Native American, and Caucasian women (55 
11 years, 28  6 kg/m2). Fitness was quantified with a symptom-limited maximal treadmill ex-
ercise test. Plasma CRP concentrations were determined with the Dade-Behring high-sensi-
tivity immunoassay. Metabolic syndrome was defined according to NCEP-ATP III. Metabolic
syndrome, CRP, and fitness varied (p  0.05) by race. Race-adjusted CRP values were directly
associated (p  0.05) with each metabolic syndrome component. After adjusting for age and
race, the relative odds of metabolic syndrome was 3.6 (95% CI  1.5  8.4) in women with el-
evated (2.0 mg/L) vs. low CRP. Adjustment for smoking, hormone therapy, body mass in-
dex (BMI), and HOMA insulin resistance did not eliminate this association (p  0.05). The as-
sociation between CRP and the metabolic syndrome was no longer significant (OR  1.3, 95%
CI  0.9  5.9, p  0.59) after adjustment for fitness.
Conclusions: Higher cardiorespiratory fitness may be an important consideration in the mi-
lieu of vascular inflammation and metabolic syndrome.
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INTRODUCTION
ACCUMULATING EVIDENCE INDICATES that C-re-active protein (CRP), a marker of subclinical
inflammation, independently predicts the risk 
of cardiovascular disease (CVD)1 and diabetes2
among women. A strong relationship has also
been shown for CRP with the prevalence3 and de-
velopment4 of the metabolic syndrome in wo-
men. The metabolic syndrome characterizes co-
existing high-risk phenotypes of hypertension,
dyslipidemia, insulin resistance, and central obe-
sity5 that multiplicatively increase the risk of
CVD6 and diabetes.7 Two recent studies showed
that the combination of elevated CRP and meta-
bolic syndrome synergistically increased the risk
of cardiovascular events and diabetes beyond
that of either variable alone.8,9 Chronic inflam-
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3Department of Exercise Science, Arnold School of Public Health, University of South Carolina, Columbia, South
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mation and the loss of metabolic homeostasis, as
indicated by the metabolic syndrome, are potent
cardiovascular antecedents and, when coexisting,
identify an individual at high risk for a future
event. Effective management of elevated CRP and
metabolic syndrome may, therefore, have signif-
icant implications for the clinical and public
health burden of CVD.
Physical activity is associated with lower car-
diovascular and diabetes risk and improved risk
factor profiles for both conditions.10 Studies have
shown that physical activity is inversely related
to CRP11,12 and to metabolic syndrome.13,14 We
reported15 an inverse association between car-
diorespiratory fitness, an objective measure of re-
cent physical activity patterns,16 and CRP,11 as
well as metabolic syndrome,13 in a cohort of
racially diverse, healthy, middle-aged women in
the Cross-Cultural Activity Participation Study
(CAPS). To our knowledge, the influence of ac-
tivity or fitness on the association between CRP
and metabolic syndrome has not yet been exam-
ined. In the current study, we report cross-sec-
tional associations among fitness, CRP, and meta-
bolic syndrome in a racially diverse sample of
women.
MATERIALS AND METHODS
Subjects were 44 African American, 45 Native
American, and 46 Caucasian women who volun-
teered to participate in CAPS. The primary aim
of CAPS was to develop physical activity surveys
for diverse populations of women.11,13,15–17 CAPS
inclusion criteria were self-reported African
American, Native American, or Caucasian eth-
nicity, absence of symptomatic disease, and ab-
sence of conditions that would preclude daily
physical activity.15 Interview-based health histo-
ries, body mass index (BMI, kg/m2), waist girth
(cm), and resting blood pressure (BP) measures
have been described.11,13,15–17
Following a 12-hour fast and 24-hour absti-
nence from exercise and smoking, antecubital
blood was collected in EDTA, centrifuged, and
frozen at 80°C until analysis. Plasma CRP 
concentrations were measured with the Dade-
Behring high-sensitivity immunoassay,11 and ele-
vated CRP was defined as 2.0 mg/L.1 We rec-
ognize that this CRP cut point is lower than that
currently recommend to define high risk.18 In the
present analysis, a CRP level of 2.0 mg/L is not
meant to imply high risk but rather to identify wo-
men whose CRP is elevated above a level consid-
ered to be normal or low risk (1.0 mg/L).1,18 A
CRP value of 2.0 mg/L approximates the median
CRP in our sample of women, and this definition
of elevated CRP is used to maintain consistency
with previously reported data from our study.11,17
Plasma triglyceride, high-density lipoprotein
(HDL) cholesterol, glucose, and insulin concen-
trations were obtained with standard automated
bioassay procedures described elsewhere.17 In-
sulin resistance was quantified using the home-
ostasis model assessment19 (HOMA-IR). The
Framingham 10-year probability16 was used as a
surrogate of coronary risk and analyzed categor-
ically at 75th percentile, which equates to a 10-
year probability 6.0% among the apparently
healthy asymptomatic cohort of CAPS women.
Metabolic syndrome was defined according 
to National Cholesterol Education Program
(NCEP)-ATP III criteria5 as 3 of the following:
abdominal obesity (waist girth 88 cm), low
HDL (50 mg/dl), high triglyceride (150
mg/dl), high glucose (110 mg/dl), and high BP
(130/85 mm Hg).
Fitness was quantified as the duration of a
physician-supervised maximal treadmill exercise
test consisting of 2-minute stages graded by 1
MET per stage11,16. Maximal exertion was seen as
achieving 85% age-predicted maximal heart
rate and perceived exertion 17 on a 20-point
Borg scale. Fitness was standardized to age-ad-
justed maximal METs (1 MET  3.5 ml O2 up-
take  kg body mass1  min1) based on the final
treadmill speed and grade.11 Women who
achieved 8.5 METs during the treadmill test
were considered to be fit, and women who
achieved 8.5 METs were considered to be unfit.
This MET value was used as a cut point because
it approximates a level of fitness associated with
significant cardiovascular risk reduction among
women.20
Summary statistics (mean, SD, frequencies)
were computed for variables in general accord
with the assumptions of normal distribution.
CRP, HOMA-IR, triglyceride, and glucose were
skewed; therefore, these variables were log (Ln)
transformed, and geometric means are reported
descriptively. Differences in CRP concentrations
according to risk factor levels, metabolic syn-
drome status, and fitness were examined with the
general linear model. Differences in proportions
were examined with chi-square analyses. Logis-
tic regression was used to examine crude and co-
variate adjusted associations between CRP and
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metabolic syndrome. Women with a CRP 2.0
mg/L were the referent group. All multivariable
analysis controlled for age and race. Additional
adjustment for hormone replacement therapy
(HRT), BMI, HOMA-IR, and cardiorespiratory fit-
ness was performed by entering each of these
variables into separate models that already in-
cluded CRP, age, and race. There were 12 women
who self-reported a history of diabetes. After ex-
cluding these women and repeating the analysis,
our primary findings were unchanged. Therefore,
results are reported for the entire study sample
including the women with diabetes. p values are
two-sided, and p  0.05 was accepted as statisti-
cally significant.
RESULTS
Participants were middle-aged and overweight
and had relatively low coronary heart disease
(CHD) risk factors (Table 1). Among all women,
the prevalence of metabolic syndrome, elevated
CRP, combined elevated CRP and metabolic 
syndrome, and a 8.5 MET level of fitness was
22.6%, 45.9%, 17.8%, and 50.4%, respectively. The
prevalence of these phenotypes varied signifi-
cantly by race (Table 2). Crude and race-adjusted
geometric mean CRP values were significantly
higher among women stratified on the presence
of metabolic syndrome and each of its compo-
nents, fasting insulin, HOMA-IR, and fitness
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TABLE 1. CHARACTERISTICS OF STUDY PARTICIPANTS
African Americans Native Americans Caucasian
n 44.0 45.0* 46.8**
Age, yearsa 56.6  10. 50.1  9*0. 54.3  10
BMI, kg/m2a 30.9  60. 28.7  6-/. 25.2  5*,**
Waist, cma 89.0  13. 88.9  12.0* 78.4  11*,**
Systolic BP, mm Hga 129.2  18... 118.2  13*0. 116.3  19*
Diastolic BP, mm Hga 79.4  90. 76.7  9-/. 76.6  9
Triglyceride, mg/dlb 81.7  0.06 114.2  0.07* 99.2  0.07
HDL, mg/dla 65.3  19. 50.9  14*. 57.6  14**
Glucose, mg/dlb 91.6  0.03 91.2  0.04* 84.4  0.02
Insulin, pmol/Lb 66.4  0.09 56.4  0.11* 36.8  0.09*,**
HOMA-IRb 15.8  0.09 13.7  0.13* 8.6  0.09*,**
CRP, mg/Lb 4.3  0.3 2.5  0.3* 2.3  1.3*
Framingham score, %a 4.6  0.41 4.3  0.50* 4.3  0.55
Treadmill time, mina 11.0  2.7.. 13.5  3*0. 15.7  3*,**
Maximal METsa 7.2  1. 9.1  2*0. 10.0  2*,**
Current smoker, % 8.7 4.4.0 6.50
Hormone replacement, % 47.8 11.1* 47.8**
Abdominal obesity, % 51.0 47.0* 17*,**..
Low HDL, % 17.0 53*.0 29*.8*
High triglyceride, % 4.0 27*.0 19*.8*
High glucose, % 15.0 20.0* 1*,**
High BP, % 70.0 38*.0 32*.8*
aMean  SD.
bGeometric mean  SE.
*p  0.05 with African American; **p  0.05 with Native American.
TABLE 2. PREVALENCE OF METABOLIC SYNDROME, ELEVATED CRP, AND FITNESS BY RACE
African American Native American Caucasian
n % n % n %
Metabolic syndrome 13 29.5. 13 28.8* 5 8.9*,**
Elevated CRP
2.0 mg/L 31 70.5. 20 44.4.* 13 28.2*,**
Metabolic syndrome 10 22.7 11 24.4* 2 4.3*,**
and
elevated CRP
Fitness 8.5 METs 8 18.2.3 24 53.3* 35 76.1*,**
*p  0.05 with African American; **p  0.05 with Native American.
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(Table 3). The proportion of women with elevated
CRP, metabolic syndrome, or both was higher
(p  0.005) among unfit than fit women (Table 4).
The proportion of women with elevated CRP was
higher in HRT users than nonusers (59.2% vs.
34.1%, p  0.01) but was not associated with
smoking status. Metabolic syndrome prevalence
was not associated with smoking or HRT status.
Figure 1 shows a direct association (p  0.0001)
between CRP concentration and the number of
metabolic syndrome components present. Ele-
vated CRP was strongly associated with meta-
bolic syndrome prevalence in unadjusted (OR 
3.61, p  0.003) and in age-adjusted and race-ad-
justed (OR  3.24, p  0.009) logistic regression
models (Table 5). Additional adjustments for
HRT, BMI, and HOMA-IR did not eliminate the
association between CRP and metabolic syn-
drome (p  0.02). However, adjustment for max-
imal MET levels of fitness eliminated the associ-
ation between CRP and metabolic syndrome
(OR  1.39, p  0.59). In this model, fitness was
inversely associated with metabolic syndrome
(OR  0.89, 95% CI  0.76 to 0.98, p  0.001) even
with adjustment for age, race, and CRP.
To examine the implications of our findings on
cardiovascular risk, we used a Framingham 10-
year probability above the 75th percentile (6%
probability of developing CHD) as a surrogate
end point. After adjusting for age and race, wo-
men with both high CRP and metabolic syn-
drome had an increased likelihood (OR  8.16,
95% CI  1.61–12.14) of an elevated Framingham
score compared with women who had neither
risk factor. This association was eliminated when
maximal METs was entered in the regression
model (OR  2.9, 95% CI  0.91–5.97, p  0.20).
DISCUSSION
Two primary findings resulted from this cross-
sectional study. First, a significant direct associa-
tion between elevated CRP and metabolic syn-
drome prevalence was observed in the racially
diverse cohort of CAPS women, similar to that
reported in predominantly white groups of U.S.
women.3,8 Second, we extend existing literature
by showing that the association between CRP 
and metabolic syndrome is eliminated once car-
diorespiratory fitness is taken into account. Given
that increasing physical activity is a front-line el-
ement of the national preventive and therapeutic
algorithm for metabolic syndrome,5 these find-
ings may have important clinical and public
health implications.
The prevalence of metabolic syndrome (25%),
elevated CRP (46%), and metabolic syndrome
combined with elevated CRP (18%) among CAPS
women was generally consistent with the preva-
LAMONTE ET AL.236
TABLE 3. CRPa (MG/L) CONCENTRATIONS ACCORDING
TO RISK FACTOR CATEGORY
Unadjusted Race adjusted
Waist, cm
88 2.5  0.2 2.4  0.3
88 4.2  0.3* 3.9  0.3*
Blood pressure, mm Hg
130/85 2.2  0.2 2.3  0.2
130/85 4.8  0.3* 4.7  0.1*
Triglyceride, mg/dl
150 2.9  0.2 2.8  0.2
150 3.9  0.5* 4.0  0.4*
HDL, mg/dl
50 2.8  0.2 2.7  0.2
50 3.4  0.4 3.3  0.2
Glucose, mg/dl
110 2.5  0.2 2.7  0.2
110 6.3  0.6* 4.9  0.5*
Insulin, pmol/Lb
44 2.2  0.3 2.5  0.3
44 3.9  0.2* 3.5  0.2*
HOMA-IRb
9.8 2.0  0.3 2.2  0.3
9.8 4.3  0.3* 3.9  0.2*
Metabolic syndrome
Absent 2.6  0.2 2.6  0.2
Present 4.8  0.4* 4.2  0.4*
Fitness
8.5 METs 3.8  0.3 3.4  0.3
8.5 METs 2.4  0.4* 2.5  0.2*
aData are geometric mean  SE.
*p  0.05.
bCut point for HOMA-IR is based on a median split
among women without diabetes or impaired fasting 
glucose.
TABLE 4. PROPORTION OF WOMEN WITH ELEVATED




n % n % p
CRP 2.0 mg/L 42 62 22 31 0.0005
Metabolic syndrome 24 35 7 10 0.0004
Elevated CRP and 17 25 5 7 0.0050
metabolic syndrome
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lence of these phenotypes (24%, 29%, and 14%,
respectively) reported by Ridker et al.8 (com-
puted from Figure 2, p.394) in a large cohort of
healthy, predominantly white women of similar
age (54 years) and BMI (27 kg/m2) to CAPS 
women. Although there were differences in the
prevalence of elevated CRP owing to differences
in case definition, the association of CRP with
each metabolic syndrome component and the
number of coexisting factors was also very simi-
lar between CAPS women and the women re-
ported on by Ridker et al.8 Ridker et al. showed
cardiovascular risk was significantly elevated
among women with either metabolic syndrome
(RR  2.3) or CRP 3.0 mg/L (RR  1.5) over the
risk in women without either factor; but the risk
was 4-fold higher among women who had both
high CRP and metabolic syndrome.8 Similar find-
ings were reported recently for cardiovascular
and diabetes outcomes in men.9 We did not have
prospective cardiovascular or diabetes events in
CAPS. Our observation that the combination of
elevated CRP and metabolic syndrome is associ-
ated with an 8-fold increase in the relative odds
of having above the 75th percentile Framingham
score is consistent with the strong direct prospec-
tive associations for this phenotype with cardio-
vascular events reported among women8 and
men.9 Collectively, available cross-sectional and
prospective data underscore the importance of
identifying asymptomatic individuals with low-
grade inflammation and metabolic syndrome for
intensive primary prevention of CVD and dia-
betes.
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FIG. 1. Race-adjusted geometric mean CRP concentrations (mg/L) according to the number of metabolic syndrome
components present in the study sample (n  52, 25, 27, 22, and 9, respectively).
TABLE 5. ASSOCIATION BETWEEN CRP AND PREVALENT METABOLIC SYNDROME
Variable in model Odds ratioa 95% CI p
CRP 2.0 mg/L 3.61 1.54–8.44 0.003
	 age 3.43 1.57–8.83 0.003
	 age 	 race 3.24 1.58–7.90 0.009
	 age 	 race 	 HRTb 3.79 1.57–9.17 0.003
	 age 	 race 	 BMIb 2.62 1.96–7.13 0.020
	 age 	 race 	 HOMA-IRb 1.82 1.66–5.02 0.020
	 age 	 race 	 Maximal METsb 1.39 0.96–5.91 0.590
aOdds ratios are for prevalent metabolic syndrome in women with CRP 2.0 mg/L after adjusting for the speci-
fied covariable(s). Women with CRP 2.0 mg/L are the referent group.
bEntered separately into a model with CRP, age, and race.
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National recommendations identify lifestyle
modifications, including regular physical activ-
ity, as the cornerstone of preventing and treating
metabolic syndrome.5 Accumulating evidence
suggests higher levels of physical activity and fit-
ness confer resistance to subclinical inflamma-
tion.11,12 Among CAPS women, maximal car-
diorespiratory fitness, an objective marker of
recent activity patterns,16 eliminated the associa-
tion between elevated CRP and metabolic syn-
drome, as well as the association of combined el-
evated CRP and metabolic syndrome with an
elevated Framingham score. The latter observa-
tion is consistent with prospective data showing
higher fitness is related to lower cardiovascular
mortality among women.20 Although cross-sec-
tional in nature, we believe the data reported
herein suggest that enhanced cardiorespiratory
fitness should be a primary mechanism for pre-
venting increases in health risk associated with
vascular inflammation and risk factor clustering,
such as metabolic syndrome. Prospective studies
in diverse populations of men and women are
needed to better understand the degree of pene-
trance that activity and fitness have in the causal
pathway of vascular inflammation and metabolic
syndrome with diabetes and CVD.
Several mechanisms have been described that
might lower CRP, metabolic syndrome, and their
associated adverse risks among active and fit in-
dividuals.10–14,17,20 Potential mechanisms include
enhanced natural killer (NK) cell activity against
acute vascular infection, improved insulin sensi-
tivity and glycemic control, and lower levels of
body fat, circulating catecholamines, and oxi-
dized low-density lipoprotein (LDL) cholesterol.
Experimental data are needed to elucidate the
specific etiological pathways through which an
active and fit lifestyle mediates the long-term risk
associated with elevated CRP and metabolic syn-
drome.
The current study has limitations that should
be considered when interpreting and generaliz-
ing the findings reported herein. This study was
an analysis of data collected during a larger in-
vestigation aimed at developing a culturally sen-
sitive physical activity survey rather than exam-
ining the complex associations among fitness,
CRP, and metabolic syndrome. Consequently, the
relatively small sample and cross-sectional de-
sign restrict the power of statistical analyses and
limit the conclusions and generalizations that can
be drawn. Several of the effect estimates were
bound by wide confidence intervals, likely owing
to the small sample size and large variance within
the data. We believe our analysis is, however, im-
portant because it is the first study to consider the
influence of fitness on the high-risk phenotype of
metabolic syndrome combined with elevated
CRP in a racially diverse sample of asymptomatic
women. We recognize that a modest genetic
transmission contributes to individual levels of
cardiorespiratory fitness.21 However, reported
exercise training gains of up to 30% and rapid de-
training-related losses22 illustrate the plasticity 
of cardiorespiratory fitness and should temper
genetic arguments against targeting fitness en-
hancement as a part of disease prevention. We
would hope that our cross-sectional data stimu-
late the design of large prospective analyses to
provide more definitive data on the influence of
fitness on elevated CRP and metabolic syndrome.
We conclude that elevated CRP is strongly 
associated with prevalent metabolic syndrome
among racially diverse women. Higher levels of
cardiorespiratory fitness appear to favorably in-
fluence the association between CRP and meta-
bolic syndrome. This observation may be a mech-
anism of cardioprotection associated with an
active and fit lifestyle and is further support for
current recommendations promoting physical ac-
tivity and fitness in the primary prevention of car-
diovascular and related diseases.
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